PrimeRFP SCOUT · Federal Contract Recompete Brief

SPE2D026F01208511978882!other medical — Dms Pharmaceutical Group Inc

Dms Pharmaceutical Group Inc holds $737.3M across 100,503 federal awards, concentrated at Department of Defense (DOD). Recompete timing centers on the Apr 26, 2027 PoP end — agencies typically plan 12–18 months ahead.

Dla Troop Support

Awarding office

Dms Pharmaceutical Group Inc

Recipient

Apr 26, 2027

PoP end

$248K

Obligated

$248K

Potential

325412

NAICS

6505

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Dms Pharmaceutical Group Inc — $90

Contract facts

Federal

Contract numberSPE2D026F0120

Also listed asSPE2D0-26-F-0120

Also listed asSPE2D021D0004-SPE2D026F0120

AgencyDla Troop Support

Awarding officeDla Troop Support

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentDms Pharmaceutical Group Inc

CAGE1UNB0

UEIPX72BSBQTKJ3

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDVSPE2D021D0004

Place of performancePARK RIDGE IL

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startMar 19, 2026

PoP end (current)Apr 26, 2027

Obligated$248K

Current value$248K

Potential value$248K

8511978882!OTHER MEDICAL is a federal award for Dla Troop Support held by Dms Pharmaceutical Group Inc. Estimated value $248K ($248K obligated). Current period of performance ends Apr 26, 2027. Place of performance: PARK RIDGE IL.

Recompete timing

Public

● Expiring in 248 days

Current PoP ends Apr 26, 2027 (248 days remaining). Agencies typically plan 12–18 months ahead — at 8.1 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Dms Pharmaceutical Group Inc — $737.3M obligated across 100,503 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($737.3M) · all agencies

Department of Defense (DOD)$737.1M · 100%Department of Veterans Affairs (VA)$193K · 0%

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract SPE2D026F0120?

SPE2D026F0120 (8511978882!other medical) is a Dla Troop Support award with a potential value of $248K, currently held by Dms Pharmaceutical Group Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is SPE2D0-26-F-0120?

SPE2D0-26-F-0120 is the dashed form of PIID SPE2D026F0120 (8511978882!other medical), held by Dms Pharmaceutical Group Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded SPE2D026F0120?

Dla Troop Support awarded SPE2D026F0120 to Dms Pharmaceutical Group Inc (potential $248K).

Who is the incumbent on SPE2D026F0120?

Dms Pharmaceutical Group Inc is the incumbent with $737.3M across 100503 related awards in SCOUT’s public footprint. The current period of performance ends Apr 26, 2027.

When does Dms Pharmaceutical Group Inc’s SPE2D026F0120 come up for recompete?

SCOUT tracks a period-of-performance end of Apr 26, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 1, 2026 · refreshed monthlyLatest procurement action Mar 19, 2026